{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:46:43Z","timestamp":1790743603683,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"17","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T00:00:00Z","timestamp":1568160000000},"content-version":"vor","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01AG056259"],"award-info":[{"award-number":["R01AG056259"]}]},{"name":"NIH","award":["R01NS086890"],"award-info":[{"award-number":["R01NS086890"]}]},{"name":"NIH","award":["DP1DA041722"],"award-info":[{"award-number":["DP1DA041722"]}]},{"name":"NIH","award":["RF1AG057409"],"award-info":[{"award-number":["RF1AG057409"]}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Biology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.cub.2018.07.046","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T14:46:11Z","timestamp":1536590771000},"page":"R909-R914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["The mouse as a model for neuropsychiatric drug development"],"prefix":"10.1016","volume":"28","author":[{"suffix":"VI","given":"James R.","family":"Howe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark F.","family":"Bear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Golshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Klann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A.","family":"Lipton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Mucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alcino J.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cub.2018.07.046_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nbt.2786","article-title":"Clinical development success rates for investigational drugs","volume":"32","author":"Hay","year":"2014","journal-title":"Nat. Biotechnol"},{"key":"10.1016\/j.cub.2018.07.046_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry\u2019s grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.cub.2018.07.046_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/npp.2013.181","article-title":"Revitalizing psychiatric therapeutics","volume":"39","author":"Hyman","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cub.2018.07.046_bib4","doi-asserted-by":"crossref","first-page":"e1001863","DOI":"10.1371\/journal.pbio.1001863","article-title":"Distinguishing between exploratory and confirmatory preclinical research will improve translation","volume":"12","author":"Kimmelman","year":"2014","journal-title":"PLoS Biol."},{"key":"10.1016\/j.cub.2018.07.046_bib5","doi-asserted-by":"crossref","first-page":"320ps321","DOI":"10.1126\/scitranslmed.aac9888","article-title":"Data gaps limit the translational potential of preclinical research","volume":"8","author":"Kleiman","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.cub.2018.07.046_bib6","doi-asserted-by":"crossref","first-page":"e1000245","DOI":"10.1371\/journal.pmed.1000245","article-title":"Can animal models of disease reliably inform human studies?","volume":"7","author":"van der Worp","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/j.cub.2018.07.046_bib7","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.cub.2018.07.046_bib8","doi-asserted-by":"crossref","first-page":"e0147215","DOI":"10.1371\/journal.pone.0147215","article-title":"When quality beats quantity: decision theory, drug discovery, and the reproducibility crisis","volume":"11","author":"Scannell","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cub.2018.07.046_bib9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/npp.2008.173","article-title":"Removing obstacles in neuroscience drug discovery: the future path for animal models","volume":"34","author":"Markou","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cub.2018.07.046_bib10","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature01262","article-title":"Initial sequencing and comparative analysis of the mouse genome","volume":"420","author":"Waterston","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cub.2018.07.046_bib11","doi-asserted-by":"crossref","first-page":"12698","DOI":"10.1073\/pnas.0914257107","article-title":"Divergence of human and mouse brain transcriptome highlights Alzheimer disease pathways","volume":"107","author":"Miller","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cub.2018.07.046_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.neuron.2013.10.045","article-title":"Cortical evolution: judge the brain by its cover","volume":"80","author":"Geschwind","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.cub.2018.07.046_bib13","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/nn.4362","article-title":"Opportunities and challenges in modeling human brain disorders in transgenic primates","volume":"19","author":"Jennings","year":"2016","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.cub.2018.07.046_bib14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejps.2013.08.018","article-title":"Animal vs. human oral drug bioavailability: do they correlate?","volume":"57","author":"Musther","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.cub.2018.07.046_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.neubiorev.2011.04.006","article-title":"Animal models of obsessive-compulsive disorder: exploring pharmacology and neural substrates","volume":"36","author":"Albelda","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.cub.2018.07.046_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/ern.10.3","article-title":"Levetiracetam: a comprehensive review","volume":"10","author":"Crepeau","year":"2010","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.cub.2018.07.046_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neuron.2014.10.042","article-title":"Rigor or mortis: best practices for preclinical research in neuroscience","volume":"84","author":"Steward","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.cub.2018.07.046_bib18","series-title":"Improving the Utility and Translation of Animal Models for Nervous System Disorders: Workshop Summary","author":"Institute of Medicine","year":"2013"},{"key":"10.1016\/j.cub.2018.07.046_bib19","doi-asserted-by":"crossref","first-page":"321fs1","DOI":"10.1126\/scitranslmed.aad9874","article-title":"Clinical trials for neurodevelopmental disorders: At a therapeutic frontier","volume":"8","author":"Jeste","year":"2016","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.cub.2018.07.046_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrd3480","article-title":"How were new medicines discovered?","volume":"10","author":"Swinney","year":"2011","journal-title":"Nat. Rev. Drug Discov"}],"container-title":["Current Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096098221830976X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096098221830976X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,11]],"date-time":"2019-09-11T01:16:04Z","timestamp":1568164564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096098221830976X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":20,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S096098221830976X"],"URL":"https:\/\/doi.org\/10.1016\/j.cub.2018.07.046","relation":{},"ISSN":["0960-9822"],"issn-type":[{"value":"0960-9822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mouse as a model for neuropsychiatric drug development","name":"articletitle","label":"Article Title"},{"value":"Current Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cub.2018.07.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}